Introduction {#section1-1179547619852621}
============

Patency of the left main coronary artery (LMCA) may be necessary in patients with patent coronary bypass grafts to the left coronary arterial system for the perfusion of branches that could not be grafted. In patients that have complete ostial occlusion of the LMCA, so that it cannot be visualized in an antegrade fashion from the aortic root, left main coronary arterial recanalization cannot be achieved antegradely. In these patients, the presence of a patent saphenous vein graft may be an opportunity for recanalization of the LMCA.

A 70-year-old male patient has represented with chest pain upon mild exertion. Biochemical examination revealed his creatinine level as 1.04 mg/dL, high-sensitive Troponin I as 2.4 pg/mL (normal range: 0-26 pg/mL), hemoglobin 10.4 g/dL (normal range: 12-16 g/dL) with a hematocrit count of 35.3% (normal range: 33%-45 %), and serum sodium as 141 mmol/L (normal range: 135-145 mmol/L). He had a history of hypertension for 20 years and Parkinsonism for 5 years. He had coronary artery bypass surgery 3 years ago and had a successful percutaneous intervention to his circumflex and right coronary artery grafts a year ago. His LMCA and LIMA (left internal mammary artery) graft have been found as patent at that time.

His medical treatment consists daily doses of 125 mg levodopa, 75 mg clopidogrel, 180 mg diltiazem, 15 mg rivaroxaban, 750 mg ranolazine, 40 mg pantoprazole, and 20 mg rosuvastatin.

Upon echocardiographic assessment, it was found that the left ventricular ejection fraction was normal; there was mild mitral and tricuspidal regurgitation; and pulmonary arterial pressure was estimated to be 30 mm Hg. There were not any significant wall motion abnormalities. Electrocardiography (ECG) showed an atrial fibrillation rhythm with an average ventricular rate of 65 bpm.

Method {#section2-1179547619852621}
======

As the LIMA graft was found to be patent in previous angiographic assessment, for the operators' ease of access, right radial artery was used rather than the left.

After cannulation of the right radial artery with a 5F Terumo Glidesheath radial artery sheath, the left coronary sinus was scanned with left Expo 3.5 and 4.0 Judkins of Boston Scientific (Tijuana, Baja California, Mexico) diagnostic catheters, and the non-coronary and right coronary sinuses were scanned with right coronary diagnostic catheter. There were no signs of an LMCA. We thought that the patient's symptoms were related to the main coronary occlusion. Namely, anastomosis-free large OM Obtuse Marginal and intermediate artery are only supplied through the graft connected to Obtuse Marginal 2 (OM2). Due to the critical stenosis in the proximal part of the anastomosis site of obtuse marginal artery, we thought that retrograde blood flow was not sufficient for intermediate artery and other great obtuse marginal vessels without graft. For this reason, we decided that the LMCA should be revascularized.

Aorta-right coronary artery (Ao-RCA) and aorta-obtuse marginal artery (Ao-OM) grafts were visualized with a Medtronic, Launcher AL1 guiding catheter (Minneapolis, MN, USA). During the visualization of the OM graft, neither the state nor the location of the LMCA could be understood. For more clear visualization of the LMCA that was thought to be occluded from its ostium, Launcher 5F Amplatz 2 guiding catheter (Medtronic) was placed selectively into the Ao-RCA graft, and a 0.014 pilot 150 percutaneous transluminal coronary angioplasty (PTCA) guidewire (Abbott Vascular, Santa Clara, CA, USA) was placed through it to the left main root in a retrograde way so as to perform an intervention. After that, 2.0 mm × 12 mm Monorail Emerge balloon (Boston Scientific--Galway, Galway, Ireland) was placed into the LMCA with the aid of this guidewire; 15 s of 10 atm predilatation was applied. Balloon was taken out and dilated with 4 atm pressure to punch with a needle to create 5 holes on it. It was reintroduced in the LMCA for use as a multi-hole catheter and the lesion was visualized with it.^[@bibr1-1179547619852621]^

Then, a 3.0 mm × 12 mm Monorail Emerge balloon (Boston Scientific--Galway) was placed into the lesion to dilate it sufficiently enough for stent insertion. A 3.0 mm × 15 mm drug eluting stent (Orsiro, Biotronik, Bülach, Switzerland) was introduced, but it could not advance beyond the stenotic lesion in the obtuse marginal coronary artery. For this reason, dilatation with a 2.0 mm × 20 mm Monorail Emerge balloon (Boston Scientific--Galway) was performed to this 90% stenotic critical lesion, located between the saphenous vein graft and the circumflex artery. To have catheter backup, Medtronic Launcher 5F Amplatz 2 guiding catheter was advanced gently, during the balloon in the obtuse marginal lesion was still inflated to anchor it. The 3.0 mm × 15 mm drug eluting stent (Orsiro, Biotronik, Bülach, Switzerland) was reintroduced to the lesion, this time passing through the lesion in the OM lesion, and was applied to the ostial LMCA lesion successfully with 22 atm dilatation ([Figure 1](#fig1-1179547619852621){ref-type="fig"}).

![ABC. Same Patient's Angiography in one year ago, (A) Picture of "LIMA-LAD graft" imaging. (B) The imaging of LMCA in one year ago. (C) Ao-RCA Graft visualization. (D) Aortic root angiography: no silhouette of the LMCA appears. (E) Obtuse Marginal (OM) saphenous graft imaging: LMCA cannot be displayed. (F) The trace of a 0.014 guidewire was advanced to aorta through OM saphenous graft retrogradely. (G) The imaging of LMCA was obtained by the use of drilled balloon after the predilatation by 2.0 mm × 20 mm balloon; this image shows that the critical LMCA lesion still exists despite the balloon dilatation. (H) The imaging of 3.0 mm × 15 mm drug eluting stent application. (I) The final view of LMCA. LMCA indicates left main coronary artery.](10.1177_1179547619852621-fig1){#fig1-1179547619852621}

No complications were encountered. A total of 75 mL radiopaque media, Omnipaque GE Healthcare (Cork, Ireland), was used. ECG evaluations performed preprocedure and immediate postprocedure; 24 h after, the procedure showed no significant changes. Serum creatinine and troponin levels did not show significant elevations at 12, 24, and 36 h after the procedure.

The patient is regularly followed up at 6-month intervals. He was last examined in January 2019. There are no active ischemic complaints.

Discussion {#section3-1179547619852621}
==========

Web-based research shows there are publications about retrograde coronary interventions via the saphenous vein graft, but there is only 1 case report about successful retrograde recanalization of a chronic ostial occlusive lesion of the LMCA via a saphenous vein graft.^[@bibr2-1179547619852621][@bibr3-1179547619852621][@bibr4-1179547619852621][@bibr5-1179547619852621]-[@bibr6-1179547619852621]^ The drilled balloon technique was not used in these studies. We think that the drilled balloon technique facilitates this process.

Left main coronary artery occlusions are frequently left untouched when the grafts are patent. We consider that, even if the left-sided grafts are patent, patency of the LMCA is beneficial for the patient as this will improve the perfusion of proximal left anterior descending, diagonal, septal, intermediary, and other circumflex branches that have not been grafted. We believe, if the grafts do not have competition with the native artery or if there are 2 or more sequential stenoses proximal to the grafted segment, recanalization of the left main or proximal lesion will be beneficial for the patient. If antegrade way is not available, retrograde approach through grafts may be used. In patients with previous coronary artery bypass grafting (CABG) surgery, native coronary lesions can be treated via the grafts. All these interventions may not only alleviate the symptoms but also decrease mortality in these patients.^[@bibr7-1179547619852621][@bibr8-1179547619852621][@bibr9-1179547619852621][@bibr10-1179547619852621][@bibr11-1179547619852621]-[@bibr12-1179547619852621]^

Conclusions {#section4-1179547619852621}
===========

It seems it is essential to recanalize the occlusions and stenotic lesions of the LMCA for improving the perfusion of non-grafted vessels of the coronary arterial system even if the left-sided grafts are patent. It is mostly probable in these patients that the retrograde approaches are going to be successful.

If the LMCA is occluded at its orifice and cannot be visualized, lesion may be recanalized through a graft in a retrograde fashion.
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